TrialHuman vaccines & immunotherapeutics2014

Immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine as a booster dose in 12- to 18-month-old children primed with 3 doses of 7-valent pneumococcal conjugate vaccine.

Usa Thisyakorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.